Pegloticase Intravenous and Ropinirole Extended-Release Tablets
Determining the interaction of Pegloticase Intravenous and Ropinirole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pegloticase
Brand name: Krystexxa
Synonyms: Pegloticase
Generic Name: ropinirole
Brand name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit
Synonyms: Ropinirole, ROPINIRole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pegloticase Intravenous-Ropinirole Hydrochloride
- Pegloticase Intravenous-Ropinirole Tablets
- Pegloticase Intravenous-Ropivacaine
- Pegloticase Intravenous-Ropivacaine Hydrochloride
- Pegloticase Intravenous-Ropivacaine Injection
- Pegloticase Intravenous-Rosac
- Ropinirole Extended-Release Tablets-Pegvaliase
- Ropinirole Extended-Release Tablets-Pegvaliase-pqpz
- Ropinirole Extended-Release Tablets-Pegvaliase-pqpz Subcutaneous
- Ropinirole Extended-Release Tablets-Pegvisomant
- Ropinirole Extended-Release Tablets-Pegvisomant Subcutaneous
- Ropinirole Extended-Release Tablets-Pembrolizumab